Global biventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis

被引:18
作者
Frustaci, A [1 ]
Chimenti, C [1 ]
Maseri, A [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Ist Cardiol, I-00168 Rome, Italy
关键词
myocarditis; coronary disease; heart failure;
D O I
10.1161/01.CIR.99.10.1295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The causal role of asymptomatic critical coronary artery obstruction in patients presenting with severe global biventricular dysfunction but no evidence of myocardial infarction is uncertain. Methods and Results-Among 291 patients aged >40 years undergoing a noninvasive (2-dimensional echocardiography) and invasive (catheterization, coronary angiography, and biventricular endomyocardial biopsy, 6 to 8 samples/patient) cardiac study because of progressive heart failure (New York Heart Association functional class III or IV) with global biventricular dysfunction and no history of myocardial ischemic events, 7 patients (2.4%; 7 men; mean age, 49+/-6.9 years) had severe coronary artery disease (3 vessels in 4 patients; 2 vessels in 1 patient, proximal occlusion of left anterior descending coronary artery in 2 patients). Left ventricular end-diastolic diameter and ejection fraction by 2-dimensional echocardiography were 73+/-10.5 mm and 23+/-6.5%, respectively, and right ventricular end-diastolic diameter and ejection fraction were 39+/-7 mm and 29+/-7.2%, respectively. Biopsy specimens showed extensive lymphocytic infiltrates with focal myocytolysis meeting the Dallas criteria for myocarditis in all patients (in 5 patients with and 2 patients without fibrosis). Cardiac autoantibodies were detected with indirect immunofluorescence in the serum of 2 patients with active myocarditis. The 2 patients with active inflammation received prednisone (1 mg.kg(-1).d(-1) for 4 weeks followed by 0.33 mg.kg(-1).d(-1) for 5 months) and azathioprine (2 mg.kg(-1).d(-1) for 5 months) in addition to conventional drug therapy for heart failure. At 8-month overall follow-up, cardiac volume and function improved considerably in immunosuppressed patients but remained unchanged in conventionally treated patients, of whom I died. Conclusions-Global biventricular dysfunction in patients with severe asymptomatic coronary artery disease and no evidence of previous myocardial infarction may be caused by myocarditis. Histologic findings may influence the treatment.
引用
收藏
页码:1295 / 1299
页数:5
相关论文
共 19 条
  • [1] Aretz T., 1986, Am J Cardiovasc Pathol, V1, P3
  • [2] BELTRAMI CA, 1994, CIRCULATION, V89, P152
  • [3] REVERSIBLE ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION - EVIDENCE FOR THE HIBERNATING MYOCARDIUM
    BRAUNWALD, E
    RUTHERFORD, JD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1467 - 1470
  • [4] ISCHEMIC CARDIOMYOPATHY
    BURCH, GE
    GILES, TD
    COLCOLOU.HL
    [J]. AMERICAN HEART JOURNAL, 1970, 79 (03) : 291 - &
  • [5] IMMUNOSUPPRESSIVE THERAPY IN THE MANAGEMENT OF ACUTE MYOCARDITIS IN CHILDREN - A CLINICAL-TRIAL
    CHAN, KY
    IWAHARA, M
    BENSON, LN
    WILSON, GJ
    FREEDOM, RM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (02) : 458 - 460
  • [6] DALY K, 1984, BRIT HEART J, V51, P30, DOI 10.1136/hrt.51.1.30
  • [7] EFFECTS OF IMMUNOSUPPRESSIVE THERAPY IN BIOPSY-PROVED MYOCARDITIS AND BORDERLINE MYOCARDITIS ON LEFT-VENTRICULAR FUNCTION
    JONES, SR
    HERSKOWITZ, A
    HUTCHINS, GM
    BAUGHMAN, KL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04) : 370 - 376
  • [8] CHLAMYDIA-PNEUMONIAE-SPECIFIC CIRCULATING IMMUNE-COMPLEXES IN PATIENTS WITH CHRONIC CORONARY HEART-DISEASE
    LINNANMAKI, E
    LEINONEN, M
    MATTILA, K
    NIEMINEN, MS
    VALTONEN, V
    SAIKKU, P
    [J]. CIRCULATION, 1993, 87 (04) : 1130 - 1134
  • [9] A CLINICAL-TRIAL OF IMMUNOSUPPRESSIVE THERAPY FOR MYOCARDITIS
    MASON, JW
    OCONNELL, JB
    HERSKOWITZ, A
    ROSE, NR
    MCMANUS, BM
    BILLINGHAM, ME
    MOON, TE
    COSTANZO, MR
    GRADY, K
    KANTROWITZ, NE
    ZELDIS, SM
    KANE, S
    COGLIANESE, ME
    TOMEO, C
    BACON, K
    MCLAUGHLIN, PR
    LIU, P
    ROSS, B
    PALACIOS, IF
    DEC, W
    BLOCK, B
    COCCASPOFFARD, D
    YOUNG, JB
    LEON, C
    CASTA, R
    KINGRY, C
    STRICKMAN, NE
    HARLAN, M
    FOWLER, N
    ENGEL, P
    NUNN, N
    DAS, SK
    SUHY, P
    KLINE, E
    GILLES, AJ
    FRENCH, WJ
    SKINNER, A
    UNVERFERTH, DV
    SARLING, R
    NEWTON, P
    WOODINGSCOTT, M
    UNTEREKER, WJ
    POLL, D
    HOFFMAN, K
    FRANK, J
    FOWLES, R
    MILLAR, K
    FREEDMAN, L
    LYVER, S
    LATHAM, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) : 269 - 275
  • [10] MILLER PJ, 1971, MED LAB TECHNOL, V28, P148